Breaking News Bar

Business News and Information

How an East Bay biotech is applying its cancer know-how to a next-generation Covid vaccine

The company's stock soared more than 150% after it laid out plans Tuesday for a vaccine that could confer broader protection against the coronavirus responsible for killing more than 2 million deaths globally, including 400,000 Americans.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear